AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Metormin-G3 Tablet SR

Prescription Icon
Prescription Required

Marketer

Serwina Pharmaceuticals Private Limited

Salt Composition

Glimepiride (3mg) + Metformin (850mg)

Overview Metormin-G3 Tablet SR

GlucoDuo SR tablets are a dual-action antidiabetic medication used in adult patients with type 2 diabetes. This formulation combines two agents to effectively manage blood glucose levels. GlucoDuo SR should be ingested with food, consistently at the same time daily for optimal results. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical supervision could lead to elevated blood glucose, potentially resulting in complications such as nephropathy, retinopathy, neuropathy, and peripheral vascular disease. This medication is part of a comprehensive diabetes management plan that includes dietary modifications, regular physical activity, and weight management as directed by your doctor. Lifestyle choices are vital to effective diabetes control. The most frequent adverse reaction is hypoglycemia (low blood sugar). Learn to recognize hypoglycemic symptoms—sweating, dizziness, headache, and tremors—and have a rapid-acting glucose source (e.g., sugary snacks or juice) readily available. Alcohol consumption elevates hypoglycemia risk and should be limited. Additional potential side effects encompass altered taste perception, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur in some individuals. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their physician before commencing treatment. Consult your doctor before using GlucoDuo SR if you are pregnant or breastfeeding. Routine blood glucose monitoring is essential, and your doctor may order periodic blood tests to assess blood cell counts and liver function.

Primary Ingredients of Metormin-G3 Tablet SR

No text was provided. Please provide the text you wish me to rephrase.

Uses of Metormin-G3 Tablet SR

Managing type 2 diabetes

Major Benefits of Metormin-G3 Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Metormin-G3 Tablet SR with a meal.

Common Side effects of Metormin-G3 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Metormin-G3 Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The extended-release Metormin-G3 Tablet should be taken with meals.

How Metormin-G3 Tablet SR works:

Glimepiride and Metformin, combined as Metormin-G3 SR tablets, offer a dual approach to diabetes management. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release, thus reducing blood sugar. Metformin, a biguanide, acts through a threefold mechanism: it decreases hepatic glucose production, slows intestinal glucose uptake, and enhances insulin responsiveness in tissues.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol and Metormin-G3 SR tablet use poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Metformin-G3 Extended Release tablets during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release metformin (Metormin-G3 Tablet SR) is contraindicated while breastfeeding due to potential infant toxicity.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Metormin-G3 SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Metormin-G3 SR tablet use. Physician consultation is essential. Routine kidney function monitoring is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Metormin-G3 SR tablets cautiously, potentially requiring dosage modification. Consult a physician. For those with mild to moderate liver disease, Metormin-G3 SR tablets are typically initiated at a low dosage; however, their use is contraindicated in cases of severe liver dysfunction.

What if you forget to take Metormin-G3 Tablet SR :

Should you forget a Metormin-G3 SR Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Metormin-G3 Tablet SR

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Metormin-G3 Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Metformin-G3 Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA—Metformin-associated lactic acidosis). While rare, this harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Metformin-G3 Tablet SR and seek immediate medical attention.
Metformin-G3 SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is unsuitable for type 1 diabetes.
Metformin-G3 Tablet SR may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged Metformin-G3 SR tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems – ataxia), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Metformin-G3 SR tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Metformin-G3 SR tablets and alcohol is unsafe. Alcohol can exacerbate Metformin's blood sugar-lowering effects, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Metormin-G3 Tablet SR
95
MRP 110
13% off